Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study - Wikidata - wikimedia - TriplyDB

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

http://www.wikidata.org/entity/Q30391256

about

Vaccination strategies in patients with solid organ transplant: evidences and future perspectives Influenza prevention and treatment in transplant recipients and immunocompromised hosts Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients Two years after pandemic influenza A/2009/H1N1: what have we learned?Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.Low seroconversion after one dose of AS03-adjuvanted H1N1 pandemic influenza vaccine in solid-organ transplant recipients Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Influenza vaccination in immunocompromised patients: efficacy and safety.Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series Challenges in the diagnosis of 2009 H1N1 in a lung transplant patient and the long-term implications for prevention and treatment: a case report.Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15.Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients.Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients.Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients.Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients Transplantation of solid organs procured from influenza A H1N1 infected donors.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients Peramivir for the treatment of influenza.Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes.Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients.Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.

P2860

Q26739160-3A1E818C-C2F4-4398-A561-3F7856658158 Q27011595-8C1BB878-17B0-4658-AA62-A154EDE2BFD5 Q27334946-56020CEE-ADC2-48D3-B692-44F4D08CF44B Q27673887-06882A6E-110B-49CD-8416-F7D357568801 Q28741451-F4799BA8-61B6-473D-B7C4-B1B9AA08B1F8 Q30224656-9BB263D1-58DC-4AF6-9553-B21C7BDC7E16 Q30353821-79C22C34-03FF-4EAA-930A-B775EA3A90EA Q30354634-513957A3-99A9-4152-85E0-5524C0A356F4 Q30356208-FA269BFA-0C49-4648-A7CC-13E42489E618 Q30357871-3BD75C7A-3A9D-4E1E-8892-F73ED6F39A16 Q30358632-778E86AE-738F-4D31-BEC0-36561FE3DA47 Q30358640-C7DB3E6D-765B-44CE-9A12-44AE6A80A1C1 Q30368680-98CED3A3-F83F-4614-8922-110C2C6D5125 Q30383985-46DF86C3-C728-420E-9C5F-C2303D5D4612 Q30397634-39BF1297-F333-44F5-B8E2-16A345C6811F Q30398670-3EB50BB1-687D-4EE5-9E41-004BD2BC7B59 Q30399281-D4C634C1-D736-44B4-9592-0EADA57D97E4 Q30399407-67EC94A9-635E-4E5D-BBF4-2DD68418F833 Q30400161-DEE21E48-A24C-438C-8591-71ADB5E059C6 Q30400403-23F1D373-8975-48F2-9248-CF1F2D2B178C Q30400983-04F26DEC-3B38-4C9C-96B7-700583C23F53 Q30401020-DBE8559A-8CF0-40CB-A649-C67D7A3FD6A0 Q30401070-32E87959-9C75-48B9-BC65-608D00A15A8F Q30402383-27E125ED-5826-43BB-8788-BBF0C5A9D041 Q30403699-2AD376ED-0BF0-4B18-A597-2E7E18A1E932 Q30405260-F99E17A3-A243-4BD3-9650-F627A8702524 Q30405856-87B4D141-BE67-4BE9-84E3-6A267FFEF9FF Q30406140-D0708C80-1EE1-451F-9DE6-0C3DC09C99C9 Q30407550-4AC80755-2D32-4BCA-98B5-2DA9419E13C5 Q30409023-38467243-68A2-4DC4-B4FE-8E80A8B62735 Q30409959-7C6A3C91-9C94-4697-9031-2C30CDD584DA Q30410436-95B0FE9C-677C-46C2-AC46-9EA7CE783E28 Q30412678-261ADC07-6E2A-425F-8570-F395D6B5197C Q30413154-6D198DCB-7481-4ECD-B175-6C9FA54B664F Q30413293-30EDD74C-A805-4DD3-80A3-885C8A760744 Q30413424-BBD07781-DF31-4FF5-A9F9-97755DA73944 Q30419842-B814B123-78E2-4C3F-8759-DCF188306A29 Q30420230-95C7F02F-28C9-45F0-8212-C9FFBFF481F9 Q30421504-E88C304A-21B3-4918-9FC4-369E5C73B243 Q30421507-F2D57CC1-2326-435C-ADA3-010A54EAD4E8

P2860

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

http://www.wikidata.org/entity/Q30391256

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@ast

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@en

type

label

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@ast

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@en

prefLabel

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@ast

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@en

P1433

Q30391256-C3E21FC2-3DA0-405D-8037-0EFBE5924EF5

P1476

Q30391256-05A1987A-161C-40AF-8505-516650121ABF

P2093

Q30391256-0D0D66C8-CD35-4BB5-91F7-9D67AE3F55D7

Q30391256-1A49506E-2BD8-4608-B655-AB81E0C3078F

Q30391256-201E6FC0-356D-485E-8F9F-EFA6D39C4073

Q30391256-237B3D07-7417-46CD-888B-74644925CA80

Q30391256-24627C33-C141-4D92-B078-BC5B50A743DF

Q30391256-2CA8FD7B-7871-4BA9-B51B-2D3126D53C0D

Q30391256-2DB322D8-D8B3-482A-9409-8CCDB602BA74

Q30391256-405D9742-1F6F-4CC5-B916-ADA5DBFDFD61

Q30391256-5C04F351-C67B-48D7-BE48-34C89A3A5C68

Q30391256-5D32DFD7-4F6B-495B-A843-C726B4D74E3A

P2860

Q30391256-326A5771-0B04-40CC-BFDD-BE57741C0D66

Q30391256-427EFFB1-9FAC-41A9-B60D-3C62CD025396

Q30391256-4FE74AA9-B36F-4CB5-997A-3E844E22B31C

Q30391256-6E1AC182-DD0B-4CC1-8C5A-8A9149EBB5A9

Q30391256-7833884F-2F75-40BF-9009-B4448A1E34DC

Q30391256-80F18014-EAAF-4998-BBDB-E6DF8A719161

Q30391256-846EE3F1-B876-4325-AD19-91691AD7F701

Q30391256-952C8522-0987-4CB5-A0C6-AFFE10AA0AF1

Q30391256-A1159776-303D-47F4-911F-A1309907DE8B

Q30391256-CBF98AC8-F26E-4DE6-A7EE-FC00EEA14DFF

P304

Q30391256-A47D942C-FD40-463E-9F07-DC0A26C950FB

P31

Q30391256-A45AA308-3750-4471-B89B-11CBFDC94FA2

P356

Q30391256-74704C9A-22C9-405D-9AC4-C67017EB86CE

P433

Q30391256-A664BC4E-A997-44D8-8F8F-290A47246A96

P478

Q30391256-10CFD0D0-C970-49DD-82A2-E4B77692D0D1

P50

Q30391256-0E2B3647-448D-4AB4-8C92-1E3709778E2A

P577

Q30391256-19ACFAF6-C429-4F23-B58E-BC36A484EE74

P698

Q30391256-345ACF38-87C8-4F38-85F0-F0911422826B

P921

Q30391256-69940F5A-1328-4DB8-A126-AE71AF9651E9

Q30391256-A80FDEEC-87B3-47C4-BBC0-8C92B316E56A

P932

Q30391256-61C9E2E9-F146-4FBC-B08F-ABA6C64DAA6B

P356

S1473-3099(10)70133-X

P1433

The Lancet Infectious Diseases

P1476

Outcomes from pandemic influen ...... ts: a multicentre cohort study

@en

P2093

American Society of Transplantation H1N1 Collaborative Study Group

http://www.w3.org/2001/XMLSchema#string

Atul Humar

http://www.w3.org/2001/XMLSchema#string

Bartholomew Bono

http://www.w3.org/2001/XMLSchema#string

Catherine Liu

http://www.w3.org/2001/XMLSchema#string

Deepali Kumar

http://www.w3.org/2001/XMLSchema#string

Doug Helmersen

http://www.w3.org/2001/XMLSchema#string

Fernanda P Silveira

http://www.w3.org/2001/XMLSchema#string

G Marshall Lyon

http://www.w3.org/2001/XMLSchema#string

Gail E Reid

http://www.w3.org/2001/XMLSchema#string

Gelareh Alavi

http://www.w3.org/2001/XMLSchema#string

P2860

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California

Emergence and pandemic potential of swine-origin H1N1 influenza virus

Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

Influenza virus infection in adult solid organ transplant recipients.

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.

Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department.

Outcome of influenza infection managed with oseltamivir in lung transplant recipients.

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

P304

521-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1473-3099(10)70133-X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20620116

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3045703

http://www.w3.org/2001/XMLSchema#string